test

A Phase 1b Open-label Study to Evaluate the Safety and Tolerability of MEDI4736 in Combination with Tremelimumab in Subjects With Advanced Non-Small Cell Lung Cancer

Conditions

Lung

What is the purpose of this trial?

The purpose of this study is to determine if ;MEDI4736 ;will be adequately tolerated in combination with tremelimumab in subjects with advanced NSCLC.


Participation Guidelines

Age:
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
MedImmune, Inc
Dates:
01/06/2014
Last Updated:
Study HIC#:
1310012856